Dr.Pairoj currently residing at Smitivej Srinakarin hospital, Bangkok, Thailand. He also serves as Deputy Managing Director at N-Health Pathology Laboratory. For more than 20 years, he has dedicated his focus on cytopathology, being the first person who established co-testing for cervical cancer screening program in Thailand. He also one of the veteran pathologists who implemented digital pathology as routine diagnosis in the country.

Dr Douglas is a medical graduate of the University of Sydney. He trained as a specialist pathologist at Concord and Royal Prince Alfred Hospitals and is a Fellow of the Royal College of Pathologists of Australasia. Dr Douglas established Histopath Diagnostic Specialists in 1998, with the aim of providing a practice committed to the highest standards of quality and traditional medical ethical values. As medical director, Dr Douglas continues to ensure that Histopath provides an independent alternative to corporate medicine, focused on doctors, patients and staff rather than shareholder profit. Dr Douglas has a special interest in dermatopathology and gastrointestinal pathology. His current focus is on the development and implementation of digital applications in surgical pathology.

Dr. Hsu Myat Wai is currently a consultant pathologist at N-Health Myanmar. She was instrumental in helping to set up the N-Health anatomic pathology lab since joining the organisation in 2019. Her current responsibilities encompass everything from lab management, training of staff, gross examination, cross country collaboration and diagnosis of cases through Digital Pathology with N-Health Thailand. Previously, Dr. Hsu was a Clinical Pathologist at Otorhinolaryngology Head and Neck Surgery Specialist Government Hospital.

Dr. Sangeeta Desai is recogonised as postgraduate teacher for MD Pathology in the University of Mumbai since September 1999. She is also recognised as a teacher of the University of Mumbai for the PhD degree in Applied Biology from 28th January 2005. She established and developed Molecular Diagnostics in Tata Memorial Centre, since the year 2003 and has actively participated in and prepared Molecular Pathology Laboratory, ACTREC, Tata Memorial Centre, for accreditation by NABL since 2009. She was also involved in NABL accreditation of Surgical Pathology and Cytology, Tata Memorial Centre.

Joined Roche last February 2019, as Pathologist in the non-commercial division of the Medical and Scientific Affairs of Roche Diagnostics, Asia Pacific. Previously Associate Pathology Director in a leading global clinical trials organization, Q 2 Solutions (a Quintiles-Quest Joint Venture), Dr. Jara-Lazaro served as Principal Investigator for Companion Diagnostics and Oncology clinical trials in the central lab of its Asia-Pacific hub based in Singapore. Prior to this role, Dr. Jara-Lazaro worked for 7 years in Singapore General Hospital Department of Pathology, subspecialized in Breast and Urologic Pathology, and was Clinical Lead of the Digital Pathology Pilot Project in collaboration with the Singapore Ministry of Health. She has multiple peer-reviewed international publications; and is a manuscript reviewer for several pathology journals.